BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/24/2020 2:37:58 AM | Browse: 574 | Download: 917
 |
Received |
|
2019-05-05 02:38 |
|
Peer-Review Started |
|
2019-05-08 02:57 |
|
To Make the First Decision |
|
2019-10-25 07:56 |
|
Return for Revision |
|
2019-10-30 06:25 |
|
Revised |
|
2019-11-05 20:18 |
|
Second Decision |
|
2019-11-27 04:02 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-11-29 15:55 |
|
Articles in Press |
|
2019-11-29 15:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-01-16 02:55 |
|
Publish the Manuscript Online |
|
2020-02-24 02:37 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Objective response rate assessment in oncology: Current situation and future expectations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nuri Faruk Aykan and Tahsin Özatlı |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nuri Faruk Aykan, MD, Professor, Department of Medical Oncology, Istinye University Medical School, Bahcesehir Liv Hospital, Atatürk Bulvarı, No. 6, Istanbul 34510, Türkiye. nfaruk@mac.com |
| Key Words |
Objective response rate; Tumor shrinkage; World Health Organization criteria; Response Evaluation Criteria in Solid Tumors; Immune Response Evaluation Criteria in Solid Tumors criteria; Early tumor shrinkage |
| Core Tip |
The tumor objective response rate is an important parameter in oncology. World Health Organization and Response Evaluation Criteria in Solid Tumors (RECIST) are anatomic response criteria developed mainly for cytotoxic chemotherapy. These criteria may not be optimal for biologic agents, some disease sites, and some regional therapies. Some alternatives of RECIST were developed, but RECIST v1.1 is validated in prospective studies, is widely accepted by regulatory agencies and has recently shown good performance for targeted cancer agents. The newest alternatives of RECIST are immune-specific response criteria for checkpoint inhibitors. Metabolic response assessments using positron emission tomography (PET) or PET/computed tomography may reflect the viability of cancer cells or functional changes that occur after anticancer treatments. |
| Publish Date |
2020-02-24 02:37 |
| Citation |
Aykan NF, Özatlı T. Objective response rate assessment in oncology: Current situation and future expectations. World J Clin Oncol 2020; 11(2): 53-73 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i2/53.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i2.53 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
